Association of human epicardial adipose tissue volume, inflammatory mediators MMP9 with coronary positive remodeling

Liangliang Zhou,Jianbin Gong,Demin Li,Guangming Lu,Dong Chen,Jing Wang
DOI: https://doi.org/10.3877/cma.j.issn.1674-0785.2014.11.001
2014-01-01
Abstract:Objective To investigate whether epicardial adipose tissue volume (EATV) and epicardial adipose tissue (EAT)-derived inflammatory cytokines are correlated with plaque vulnerability in patients presenting with coronary heart disease (CHD). Methods A total of 80 patients were assessed for severity of coronary artery stenosis and EATV by 64-slice dual-source cardiac computed tomography(CT) scans. These patients were also screened to determine levels of adipokines in pericardial blood and insulin resistance indices. 40 patients were confirmed to have CHD utilizing digital subtraction angiography (DSA), and the other 40 patients whom were assessed without coronary stenosis prior to valve replacement surgery were classified as non-CHD. The vascular remodeling indices were measured in order to determine any significant correlations with EATV. Samples of EAT and thoracic adipose tissue (TAT) were collected during the coronary artery bypass graft (CABG) surgery that 40 of the CHD patients received. Samples&nbsp;were probed for mRNA level and protein level expression of MMP9. Results (1)The EATVs were significantly higher in the CHD group compared to those of the VHD group [(121.43±40.60)cm3 vs. (75.61±21.41)cm3, P=0.001]. (2) Subgroup analysis of the CHD patients demonstrated that EATV in patients with positive remodeling was significantly higher[(127.63±42.00)cm3 vs. (95.49±25.36)cm3, P=0.001] than that of the non-positive remodeling group. (3)Logistic regression analysis indicated that EATV was an independent risk factor for positive vascular remodeling(P=0.01). (4)Compared to 40 VHD patients, the 40 CHD patients who received CABG surgery, presented higher levels of mRNA and protein expression of leptin and MMP9 in EAT (P<0.01). However, there was no significant difference (P>0.05) in mRNA and protein expression of MMP9 within the TAT of CHD and VHD patients. Conclusions It has been determined that EATV is an independent risk factor for both CHD and plaque vulnerability. Levels of inflammatory cytokines secreted by EAT and TAT of CHD patients were found to be significantly greater than those of VHD patients. Levels of inflammatory cytokines produced by EAT correlate with EATVs; therefore, controlling levels of EATV and inflammation may reduce positive remodeling and decrease the risk of coronary heart disease.
What problem does this paper attempt to address?